Bank of America
EIDX

Bank of America’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bank of America’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,100
Closed -$112K – 7595
2019
Q3 		$112K Buy
+3,100
New +$121K ﹤0.01% 5994

Bank of America's EIDX Position: Q1 2021 in Review

Bank of America sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 17,877 shares — an estimated $2.35M sold.

Bank of America first reported a position in EIDX in Q2 2018 and held it in 11 quarters. The position peaked at $2.35M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Bank of America reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of America sold 17,877 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $2.35M.
  • Bank of America first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2018 and held it in 11 quarters.
  • Bank of America's Eidos Therapeutics, Inc. Common Stock position peaked at $2.35M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.